Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

GT Biopharma (GTBP) EBT Margin (2018 - 2021)

GT Biopharma (GTBP) has disclosed EBT Margin for 7 consecutive years, with 82727.27% as the latest value for Q4 2021.

  • On a quarterly basis, EBT Margin changed N/A to 82727.27% in Q4 2021 year-over-year; TTM through Dec 2021 was 264550.0%, a N/A change, with the full-year FY2025 number at 9784.25%, changed N/A from a year prior.
  • EBT Margin was 82727.27% for Q4 2021 at GT Biopharma, up from 40.6% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 82727.27% in Q4 2021 to a low of 40.6% in Q4 2019.
  • A 3-year average of 26066.19% and a median of 10789.03% in 2018 define the central range for EBT Margin.